Henderson Wendy A, Xiang Lichen, Fourie Nicolaas H, Abey Sarah K, Ferguson Eric G, Diallo Ana F, Kenea Natnael D, Kim Chang Hee
Division of Intramural Research , National Institute of Nursing Research , National Institutes of Health , Department of Health and Human Services , Bethesda , MD 20892 , USA . Email:
GoDx , 510 Charmany Drive, Suite 257 , Madison , WI 53719 , USA . Email:
Anal Methods. 2018 Dec 7;10(45):5358-5363. doi: 10.1039/c8ay01475b. Epub 2018 Sep 20.
Diarrheal diseases claim the lives of 1300 children daily, mostly in the developing world. We have developed a simple lateral flow assay capable of detecting and EPEC DNA and RNA rapidly (<15 minutes) at the point-of-need, directly from stool without nucleic acid extraction or molecular amplification. The limit of detection of the method is 1 nM using synthetic DNA target substrates spiked into stool. However, due to the endogenous amplification of the 23S rRNA targets, we were able to detect the endogenous EPEC in pea-sized (5 mg) stool without labor-intensive and time-consuming nucleic acid purification or target amplification using enzymes. The significance of this method is that it is rapid (<15 minutes) and simple (without nucleic acid purification or molecular amplification) and does not require instrumentation, or access to a laboratory, cold chain or electric power. Thus, it is well-suited for point-of-need use in remote and/or resource-limited settings in the developing world where the mortality due to diarrheal diseases is especially high. The rapid testing of stool pathogens in real time at the point-of-need will decrease the loss of patients to follow-up, and enable patients to be treated earlier with the appropriate therapeutics in both the developed and developing world settings.
腹泻疾病每天导致1300名儿童死亡,其中大多数发生在发展中世界。我们开发了一种简单的侧向流动检测方法,能够在现场(无需核酸提取或分子扩增)直接从粪便中快速(<15分钟)检测肠致病性大肠杆菌(EPEC)的DNA和RNA。使用添加到粪便中的合成DNA靶标底物,该方法的检测限为1 nM。然而,由于23S rRNA靶标的内源性扩增,我们能够在豌豆大小(5 mg)的粪便中检测到内源性EPEC,而无需使用酶进行费力且耗时的核酸纯化或靶标扩增。该方法的意义在于它快速(<15分钟)且简单(无需核酸纯化或分子扩增),不需要仪器设备,也无需进入实验室、冷链或电力供应。因此,它非常适合在腹泻疾病死亡率特别高的发展中世界的偏远和/或资源有限地区进行现场使用。在现场实时快速检测粪便病原体将减少失访患者的数量,并使发达国家和发展中国家的患者都能更早地接受适当的治疗。